ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) Operating margin 2017–2025
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) operating margin by fiscal year — reported operating income divided by reported revenue.
-20.6%FY2025 · since FY2017: -115.7% → -20.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -20.6% | +70.2 pp |
| FY2024 | -90.8% | +42.5 pp |
| FY2023 | -133.3% | -25.3 pp |
| FY2022 | -108.0% | +27.4 pp |
| FY2021 | -135.4% | +19.9 pp |
| FY2020 | -155.3% | -63.2 pp |
| FY2019 | -92.1% | -2.8 pp |
| FY2018 | -89.4% | +26.3 pp |
| FY2017 | -115.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice